Regencell Bioscience Holdings Ltd (RGC)
4.79
+0.14
(+3.01%)
USD |
NASDAQ |
Apr 30, 13:16
Regencell Bioscience Holdings Price: 4.79 for April 30, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 29, 2024 | 4.90 | 4.90 | 4.35 | 4.65 | 5027.00 |
Apr 26, 2024 | 5.35 | 5.35 | 5.35 | 5.35 | 0.000 |
Apr 25, 2024 | 5.00 | 5.35 | 5.00 | 5.35 | 1147.00 |
Apr 24, 2024 | 5.12 | 5.63 | 5.10 | 5.10 | 2609.00 |
Apr 23, 2024 | 6.35 | 8.60 | 5.05 | 5.70 | 27364.00 |
Apr 22, 2024 | 6.00 | 6.44 | 5.651 | 6.44 | 3132.00 |
Apr 19, 2024 | 5.21 | 5.55 | 5.150 | 5.55 | 1338.00 |
Apr 18, 2024 | 4.63 | 6.150 | 4.555 | 5.22 | 11218.00 |
Apr 17, 2024 | 3.48 | 4.80 | 3.48 | 4.738 | 8531.00 |
Apr 16, 2024 | 3.71 | 3.71 | 3.71 | 3.71 | 0.000 |
Apr 15, 2024 | 3.85 | 4.049 | 3.70 | 3.71 | 2857.00 |
Apr 12, 2024 | 3.55 | 4.17 | 3.54 | 3.81 | 1411.00 |
Apr 11, 2024 | 3.55 | 3.80 | 3.55 | 3.80 | 462.00 |
Apr 10, 2024 | 3.81 | 3.81 | 3.67 | 3.67 | 1442.00 |
Apr 09, 2024 | 3.62 | 3.88 | 3.55 | 3.79 | 13798.00 |
Apr 08, 2024 | 3.900 | 3.900 | 3.900 | 3.900 | 0.000 |
Apr 05, 2024 | 3.90 | 3.90 | 3.70 | 3.900 | 2102.00 |
Apr 04, 2024 | 4.000 | 4.000 | 3.54 | 3.72 | 7167.00 |
Apr 03, 2024 | 4.25 | 4.25 | 3.60 | 3.865 | 2879.00 |
Apr 02, 2024 | 4.19 | 4.39 | 3.92 | 4.00 | 4164.00 |
Apr 01, 2024 | 3.82 | 4.200 | 3.82 | 3.90 | 4738.00 |
Mar 28, 2024 | 3.62 | 4.995 | 3.167 | 4.50 | 56304.00 |
Mar 27, 2024 | 3.76 | 3.76 | 3.47 | 3.47 | 776.00 |
Mar 26, 2024 | 4.48 | 4.48 | 3.16 | 3.45 | 10248.00 |
Mar 25, 2024 | 3.50 | 3.81 | 3.360 | 3.70 | 4828.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
3.45
Minimum
Mar 26 2024
46.33
Maximum
Aug 25 2021
22.58
Average
24.58
Median
Price Benchmarks
Global Pharmatech Inc | 0.15 |
NovaBay Pharmaceuticals Inc | 0.0797 |
Palatin Technologies Inc | 1.90 |
iBio Inc | 1.735 |
Theriva Biologics Inc | 0.3991 |
Price Related Metrics
Market Cap | 62.33M |